ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,957,973 | +50.8% | 1,105,106 | +71.6% | 0.03% | +47.4% |
| Q1 2024 | $11,908,854 | +35.7% | 644,070 | +129.8% | 0.02% | +11.8% |
| Q4 2023 | $8,774,909 | +97.8% | 280,259 | +31.6% | 0.02% | +41.7% |
| Q3 2023 | $4,437,232 | +645.9% | 212,919 | +757.2% | 0.01% | +500.0% |
| Q2 2023 | $594,894 | +21.6% | 24,839 | -19.1% | 0.00% | -33.3% |
| Q4 2022 | $489,078 | +57.3% | 30,721 | +139.5% | 0.00% | 0.0% |
| Q1 2022 | $311,000 | -87.9% | 12,825 | -73.4% | 0.00% | -91.9% |
| Q4 2020 | $2,578,000 | -67.1% | 48,226 | -70.1% | 0.04% | -67.8% |
| Q2 2020 | $7,825,000 | +2980.7% | 161,431 | +2617.7% | 0.12% | +1337.5% |
| Q4 2019 | $254,000 | – | 5,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |